AU2001247444A1 - Erbeta-mediated gene expression - Google Patents
Erbeta-mediated gene expressionInfo
- Publication number
- AU2001247444A1 AU2001247444A1 AU2001247444A AU4744401A AU2001247444A1 AU 2001247444 A1 AU2001247444 A1 AU 2001247444A1 AU 2001247444 A AU2001247444 A AU 2001247444A AU 4744401 A AU4744401 A AU 4744401A AU 2001247444 A1 AU2001247444 A1 AU 2001247444A1
- Authority
- AU
- Australia
- Prior art keywords
- erbeta
- gene expression
- mediated gene
- mediated
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18960500P | 2000-03-15 | 2000-03-15 | |
US60189605 | 2000-03-15 | ||
PCT/US2001/008276 WO2001069262A1 (en) | 2000-03-15 | 2001-03-15 | ERβ-MEDIATED GENE EXPRESSION |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001247444A1 true AU2001247444A1 (en) | 2001-09-24 |
Family
ID=22698029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001247444A Abandoned AU2001247444A1 (en) | 2000-03-15 | 2001-03-15 | Erbeta-mediated gene expression |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020115117A1 (en) |
AU (1) | AU2001247444A1 (en) |
WO (1) | WO2001069262A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2365811A1 (en) * | 2001-12-21 | 2003-06-21 | Institut De Cardiologie | A new gene therapy using antisense strategy to estrogen receptors (er .alpha. and/or er .beta.) to optimize vascular healing and cardioprotection after vascular injury |
US6982253B2 (en) | 2002-06-05 | 2006-01-03 | Supergen, Inc. | Liquid formulation of decitabine and use of the same |
US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
AU2012302051B2 (en) | 2011-08-30 | 2017-04-27 | Astex Pharmaceuticals, Inc. | Decitabine derivative formulations |
EP3316685A4 (en) | 2015-07-02 | 2019-03-13 | Otsuka Pharmaceutical Co., Ltd. | Lyophilized pharmaceutical compositions |
WO2019025863A2 (en) | 2017-08-03 | 2019-02-07 | Otsuka Pharmaceutical Co., Ltd. | Drug compound and purification methods thereof |
-
2001
- 2001-03-15 AU AU2001247444A patent/AU2001247444A1/en not_active Abandoned
- 2001-03-15 WO PCT/US2001/008276 patent/WO2001069262A1/en active Application Filing
- 2001-03-15 US US09/810,157 patent/US20020115117A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001069262A1 (en) | 2001-09-20 |
US20020115117A1 (en) | 2002-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002313559A1 (en) | Genes | |
AU2001262847A1 (en) | Language-understanding | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2001265089A1 (en) | Rc-timer scheme | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2002220553A1 (en) | Bioreactor | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AUPQ262599A0 (en) | Gene expression | |
AU2001242625A1 (en) | Gene sequence | |
AU2001264247A1 (en) | GASC1 gene | |
AU2001240103A1 (en) | Reproduction-specific genes | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001247444A1 (en) | Erbeta-mediated gene expression | |
AUPQ749100A0 (en) | New epilespy gene | |
AU2001246864A1 (en) | Hypotensors | |
AU2001285743A1 (en) | Adipose-related gene | |
AU7567101A (en) | Gene expression system | |
AU2001284265A1 (en) | Genetic study | |
AU2001262711A1 (en) | Cytoprotectors | |
AU2001260192A1 (en) | Glycinamides | |
AU2001226668A1 (en) | Crankshaft-starter-generator |